Wealthcare Advisory Partners’s Alexion Pharmaceuticals ALXN Stock Holding History

Wealthcare Advisory Partners’s Portfolio ALXN Stock Details ALXN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-1,438	Closed	-$220K	–	2099
2021 Q1	$220K	Buy	+1,438	New	+$222K	0.02%	458
2020 Q2	–	Sell	-23	Closed	-$2K	–	1503
2020 Q1	$2K	Buy	23 +9	+64%	+$883	﹤0.01%	1345
2019 Q4	$2K	Hold	14	–	–	﹤0.01%	1297
2019 Q3	$1K	Hold	14	–	–	﹤0.01%	1323
2019 Q2	$2K	Hold	14	–	–	﹤0.01%	1220
2019 Q1	$2K	Hold	14	–	–	﹤0.01%	1125
2018 Q4	$1K	Hold	14	–	–	﹤0.01%	1181
2018 Q3	$2K	Hold	14	–	–	﹤0.01%	1147
2018 Q2	$2K	Hold	14	–	–	﹤0.01%	1149
2018 Q1	$2K	Sell	14 -3	-18%	-$359	﹤0.01%	986
2017 Q4	$2K	Buy	17 +3	+21%	+$365	﹤0.01%	947
2017 Q3	$2K	Buy	+14	New	+$1.9K	﹤0.01%	787

Other funds holding ALXN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Farallon Capital Management San Francisco, California $15.3B AUM 50.95% 1-Year Est. Return

HBK Investments Dallas, Texas $7.94B AUM 55.6% 1-Year Est. Return

Davidson Kempner Capital Management New York $4.65B AUM 56.47% 1-Year Est. Return

Adage Capital Partners

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Pentwater Capital Management Naples, Florida $14.1B AUM 58.13% 1-Year Est. Return

Millennium Management

Millennium Management New York $134B AUM 35.51% 1-Year Est. Return

UBS O'Connor Chicago, Illinois $3.37B AUM 63.08% 1-Year Est. Return